Medical Condition News

RSS

Amgen to discuss application for LUMAKRAS® (sotorasib) for the treatment of KRAS G12C-positive NSCLC at FDA advisory committee meeting

Amgen today announced the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) will review data supporting the supplemental New Drug Application (sNDA) for the full approval of LUMAKRAS® (sotorasib) for adults with previously treated locally advanced or metastatic KRAS G12C-mutated non-small cell lung cancer (NSCLC) at a meeting on Oct. 5, 2023.

From AMGEN 1 Sep 2023

Bridging the gap: Postnatal research offers clues to tackling maternal obesity

Postnatal dietary patterns, physical activity status, and changes in body weight among obese women living in a highly deprived region in the UK.

1 Sep 2023

Biomarkers unveil insights into post-COVID-19 syndrome variability

Researchers studied a prospective observation cohort of patients with post-coronavirus disease 2019 syndrome.

1 Sep 2023

The efficacy and safety of anti-androgens in the management of hormonal and clinical features of PCOS

The safety and efficacy of anti-androgens in managing polycystic ovary syndrome (PCOS).

1 Sep 2023

Link between daily diet soda and aspartame intake in early life with autism in males

The association between maternal daily consumption of diet sodas or aspartame during pregnancy and the risk of autism in offspring.

1 Sep 2023

Can the consumption of colorful fruits and vegetables improve the management of gestational diabetes?

A new paper explores the dietary effects of consuming colorful fruits and vegetables (CFV).

1 Sep 2023

Low-dose aspirin linked to 15% lower risk of type 2 diabetes in older adults

New research to be presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2-6 October) shows that use of low dose (100mg daily) aspirin among older adults aged 65 years and older is associated with a 15% lower risk of developing type 2 diabetes.

31 Aug 2023

$Simple strategies to strengthen bones could lead to substantial decrease in hip fractures$

Simple strategies to strengthen bones could lead to substantial decrease in hip fractures

Simple strategies to strengthen your bones, implemented by the whole community not just those at higher risk, could lead to a substantial decrease in hip fractures, a new Australian study suggests.

31 Aug 2023

Study shows strong link between depression and inflammation in obese patients before and after bariatric surgery

Research funded by the National Institute for Health and Care Research (NIHR) has shown that higher levels of inflammation in the blood of patients with obesity undergoing bariatric surgery predicts poorer weight loss six months after the procedure.

31 Aug 2023

New gene therapy offers hope for beta thalassemia patients

UCSF Benioff Children's Hospital Oakland provides new therapy to first patient since FDA approval.

31 Aug 2023

Discovery could lead to more effective treatments for cancers

Case Western Reserve University biochemical researchers have identified a new function of a key protein that leads to cancer–a finding they believe could lead to more effective treatments for a range of cancers and other diseases.

31 Aug 2023

IBS researchers discover new insights into the regulation of fat metabolism

This is a significant development that brings hope to the one billion individuals with obesity worldwide. Researchers led by Director C. Justin LEE from the Center for Cognition and Sociality (CCS) within the Institute for Basic Science (IBS) have discovered new insights into the regulation of fat metabolism.

31 Aug 2023

Boosters slow antibody waning but hit a ceiling: Long-term COVID study reveals limits of immunity

The study tracks the long-term kinetics of antibody responses to SARS-CoV-2 after vaccination and infections in New York healthcare workers from 2020 to 2023. It reveals that antibody waning is slower after booster shots, but there's an upper limit to antibody levels, which gradually lowers with repeated SARS-CoV-2 exposures and vaccinations.

31 Aug 2023

Alzheimer's screening just got easier, more accurate with new blood test

A new blood test called p-tau217 shows promise as an Alzheimer's disease biomarker, and when used in a two-step workflow very high accuracy to either identify or exclude brain amyloidosis, the most important and earliest pathology.

31 Aug 2023

Blood NfL levels correlate with severity of Alzheimer's disease pathology

Neuroscience researchers at Wayne State University published a review article that confirms the usefulness of neurofilament light (NfL) blood levels to predict the likelihood and rate of progression of neurodegeneration in Alzheimer's disease.

31 Aug 2023

Universal approach could potentially expand CAR T cell therapy to all blood cancers

A broad new strategy could hold hope for treating virtually all blood cancers with CAR T cell therapy, which is currently approved for five subtypes of blood cancer.

31 Aug 2023

ER-phagy alleviates drug-induced cardiomyopathy in cancer patients

A cell contains many specialized subunits, called organelles, that carry out important tasks such as energy generation, protein synthesis, and calcium outflux. But what happens when something goes wrong with one of the organelles?

31 Aug 2023

Study explores associations between digital media use and psychotic experiences in young adults

On average, young adults in Canada spend several hours on their smartphones every day. Many jump from TikTok to Netflix to Instagram, putting their phone down only to pick up a video game controller.

31 Aug 2023

Exploring the role of the metabolic syndrome in individual mechanisms of liver fibrosis

Chronic liver injury results in the development of liver fibrosis in approximately 25% of individuals in response to diverse insults, and several aspects of the development of liver injury appear to be common to a variety of initiating factors.

31 Aug 2023

Largest genetic study of epilepsy finds new risk genes

The largest genetic study of its kind, coordinated by the International League Against Epilepsy, including scientists from FutureNeuro at RCSI University of Medicine and Health Sciences, has discovered specific changes in our DNA that increase the risk of developing epilepsy.

31 Aug 2023

Medical Condition News

Amgen to discuss application for LUMAKRAS® (sotorasib) for the treatment of KRAS G12C-positive NSCLC at FDA advisory committee meeting

Bridging the gap: Postnatal research offers clues to tackling maternal obesity

Biomarkers unveil insights into post-COVID-19 syndrome variability

The efficacy and safety of anti-androgens in the management of hormonal and clinical features of PCOS

Link between daily diet soda and aspartame intake in early life with autism in males

Can the consumption of colorful fruits and vegetables improve the management of gestational diabetes?

Low-dose aspirin linked to 15% lower risk of type 2 diabetes in older adults

Simple strategies to strengthen bones could lead to substantial decrease in hip fractures

Study shows strong link between depression and inflammation in obese patients before and after bariatric surgery

New gene therapy offers hope for beta thalassemia patients

Discovery could lead to more effective treatments for cancers

IBS researchers discover new insights into the regulation of fat metabolism

Boosters slow antibody waning but hit a ceiling: Long-term COVID study reveals limits of immunity

Alzheimer's screening just got easier, more accurate with new blood test

Blood NfL levels correlate with severity of Alzheimer's disease pathology

Universal approach could potentially expand CAR T cell therapy to all blood cancers

ER-phagy alleviates drug-induced cardiomyopathy in cancer patients

Study explores associations between digital media use and psychotic experiences in young adults

Exploring the role of the metabolic syndrome in individual mechanisms of liver fibrosis

Largest genetic study of epilepsy finds new risk genes

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News